Cargando…
Dalbavancin Use for the Treatment of Methicillin-resistant Staphylococcus aureus Pneumonia
Dalbavancin is a lipoglycopeptide with a long half-life that allows infrequent dosing. It is indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible organisms, including Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). Although this ag...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497404/ https://www.ncbi.nlm.nih.gov/pubmed/28706403 http://dx.doi.org/10.4103/jpp.JPP_2_17 |